BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.250
+0.040 (1.81%)
Apr 6, 2026, 9:45 AM EDT - Market open
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $10 million as of April 6, 2026. Its market cap has decreased by -22.51% in one year.
Market Cap
10.00M
Enterprise Value
4.32M
1-Year Change
-22.51%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $10.00M, a decrease of -70.42%. That is a compound annual growth rate of -7.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 10.00M | -23.69% |
| Dec 31, 2025 | 13.10M | -44.21% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imunon | 10.95M |
| Cellectar Biosciences | 10.81M |
| BioAtla | 10.80M |
| BioVie | 10.71M |
| Theriva Biologics | 10.55M |
| Acurx Pharmaceuticals | 10.51M |
| NewcelX | 10.28M |
| Reviva Pharmaceuticals Holdings | 9.22M |